Eko Analysis Software vs Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Eko Analysis Software is designed as a diagnostic aid for clinicians, leveraging AI to detect cardiovascular diseases like heart murmurs and atrial fibrillation through stethoscope integration. In contrast, the Jewel Patch Wearable Cardioverter Defibrillator is a therapeutic device that continuously monitors for and treats life-threatening arrhythmias via an integrated defibrillator. While both utilize AI for cardiac monitoring, Eko focuses on diagnostic assistance for a broader range of conditions, whereas Jewel provides immediate, life-saving intervention for specific severe arrhythmias.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if you need an AI-powered diagnostic aid for early detection and ongoing monitoring of cardiovascular conditions like heart murmurs and and atrial fibrillation. This tool is ideal for clinicians seeking to enhance their auscultation capabilities with AI-driven insights, record and visualize heart sounds and ECGs, and securely store patient data for comprehensive assessment and trend analysis.

View Eko Analysis Software →

Choose Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) if…

Choose Jewel Patch Wearable Cardioverter Defibrillator if your patient requires continuous, discreet monitoring and immediate therapeutic intervention for life-threatening arrhythmias. This device is best suited for individuals at high risk of sudden cardiac arrest who need a highly compliant, water-resistant solution that can automatically detect and treat dangerous heart rhythms, providing a critical safety net outside of a hospital setting.

View Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Analysis Software Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)
Pricing Freemium with subscription for full features Unknown
Deployment Cloud-based Wearable device with mobile app
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Analysis Software

Tool A (Eko Analysis Software) focuses on clinician usability, offering an intuitive mobile app interface for recording, visualizing, and analyzing heart sounds and ECGs. Its freemium model and clear feature sets suggest a user-friendly experience for healthcare professionals. Tool B's (Jewel P-WCD) usability centers on patient compliance for a wearable device, which is a different aspect than direct interaction with an AI diagnostic tool.

Clinical Value

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

While both tools offer significant clinical value, Tool B (Jewel P-WCD) provides both continuous monitoring and *therapeutic intervention* for life-threatening arrhythmias, including defibrillation. Tool A (Eko Analysis Software) is a diagnostic aid for early detection. The ability to actively treat life-threatening conditions gives Tool B a higher immediate clinical impact in critical situations.

Pricing & Value

Eko Analysis Software

Tool A (Eko Analysis Software) offers a transparent freemium model with clear subscription tiers for advanced features, allowing users to understand costs upfront. Tool B (Jewel P-WCD) requires contacting the vendor for pricing, which lacks transparency and makes it difficult to assess value without direct engagement.

Enterprise Readiness

Eko Analysis Software

Tool A (Eko Analysis Software) is explicitly cloud-based, HIPAA compliant, and offers a BAA, making it straightforward for enterprise integration. It also lists broader specialties, indicating wider applicability. Tool B (Jewel P-WCD) involves a hardware device with associated platforms, and its HIPAA compliance and BAA are described as 'expected' and 'likely', which are less definitive than Tool A's explicit claims.

Innovation

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Tool B (Jewel P-WCD) demonstrates higher innovation by combining a discreet, water-resistant, patch-based wearable form factor with continuous monitoring, AI-driven arrhythmia detection, and *therapeutic defibrillation*. This integration of diagnostic, AI, and life-saving therapeutic capabilities in a high-compliance wearable device represents a more significant advancement in patient care.

Support & Docs

Tie

Both companies, as providers of FDA-cleared medical devices and software, are expected to offer comprehensive support and documentation. Eko provides a help center with user manuals, FAQs, and contact options. Element Science offers patient guides and instructions for use, including instructional videos. Without specific comparative metrics on the quality or breadth of support, it is difficult to definitively choose a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Analysis Software Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)
Name Eko Analysis Software Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)
Company Eko Devices Element Science, Inc.
Primary Function Assists clinicians in early detection of cardiovascular diseases like heart murmurs and atrial fibrillation; records, plays back, and annotates heart sounds and ECGs. Continuous heart monitoring and treatment of life-threatening arrhythmias; functions as a wearable cardioverter defibrillator.
AI/ML Capability FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, detection of normal sinus rhythm, calculation of cardiac time intervals. Machine learning detection algorithm for arrhythmia detection.
Device Type Software (integrates with digital stethoscopes) Patch-based wearable cardioverter defibrillator

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Eko Analysis Software is an FDA-cleared AI-powered tool designed to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. In contrast, the Jewel P-WCD is an FDA-cleared hardware device with a machine learning algorithm for continuous heart monitoring, specifically designed to detect and treat life-threatening arrhythmias.
The Eko Analysis Software is FDA-cleared for the detection of heart murmurs and atrial fibrillation (AFib), as well as normal sinus rhythm, and calculates cardiac time intervals. The Jewel P-WCD is an FDA-cleared wearable cardioverter defibrillator designed to detect and treat specific life-threatening arrhythmias.
Eko Analysis Software provides secure cloud-based storage of recordings within the US, allowing for recording, playback, and annotation of heart sounds and ECGs. The Jewel P-WCD includes an associated Jewel Mobile App that transmits near real-time therapy information to the patient's medical team.
Both tools offer continuous monitoring capabilities, but with different approaches. The Eko Analysis Software supports ongoing diagnostic assessment through repeated auscultation and recording for early detection. The Jewel P-WCD is specifically designed for continuous heart rhythm monitoring and treatment of life-threatening arrhythmias, emphasizing high patient compliance for extended wear, with median wear times over 23 hours per day.

Backers

Who funded each tool's parent company.

Eko Analysis Software

AI Tool Finder
AI-powered search. Results may not be comprehensive.